Niki BioSolutions, Inc. (NIKI) stock
NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
$1.60+0.10 (+6.67%)
Close on Nov 18, 2026Market cap $13.03MP/E –Yield –
Niki BioSolutions operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Niki BioSolutions's operating cash flow for the twelve months ending Dec 31, 2025 was -$1.84M. For fiscal 2025 it was -$1.84M. The highest annual figure on record is -$1.19M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.84M | – |
| FY2024 | Dec 31, 2024 | -$1.19M | – |
| FY2023 | Dec 31, 2023 | -$7.72M | – |
| FY2022 | Dec 31, 2022 | -$12.32M | – |
| FY2021 | Dec 31, 2021 | -$14.65M | – |
| FY2020 | Dec 31, 2020 | -$15.93M | – |
| FY2019 | Dec 31, 2019 | -$13.38M | – |
| FY2018 | Dec 31, 2018 | -$10.04M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$535.72K | – |
| Q3 FY2025 | Sep 30, 2025 | -$484.28K | – |
| Q4 FY2024 | Dec 31, 2024 | $119.65K | – |
| Q3 FY2024 | Sep 30, 2024 | -$28.49K | – |
See a number that looks wrong?